Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 26.3124.7321.2019.1419.55

What is the latest Core EBITDA Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 26.31 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202426.31
Mar202324.73
Mar202221.20
Mar202119.14
Mar202019.55

How is Core EBITDA Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 26.31
6.39
Mar2023 24.73
16.65
Mar2022 21.2
10.76
Mar2021 19.14
-2.10
Mar2020 19.55 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,471.6 Cr -0.6% -4.8% 27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.6%

-4.8%

27.7%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses